LncRNA PLAC2 and XiaP overexpression increased HCC cell viability, while lncRNA PLAC2 l silencing decreased HCC cell viability under 2 and 4 μg/ml cisplatin treatment (Figure 3, p < 0.05). Here, XIAP is linked to hepatocellular carcinoma.